CXCR4 in human osteosarcoma malignant progression. The response of osteosarcoma cell lines to the fully human CXCR4 antibody MDX1338.

J Bone Oncol · 2019 · PMC6543022 · PMID 31193811

Europe PMC DOI

hedged sentence

0.6000

closest p · 12.0× alpha

0.6000

boldest claim

The sentences

did not reach statistical significancep == 0.6not close (p > 0.1)

OS cell sensitivity to CXCR4 antagonists CXCR4 mRNA expression (2 −ΔΔCT ) was significantly higher in U2OS (4.05, p = =0.04) and 143B (1052.7, p = =0.01) than in osteoblasts (0.03), while in SAOS-2 the difference of expression did not reach statistical significance (0.57, p == 0.6).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.